Sections

Alphabetical list:

A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9

News: November 21, 2009

Diabetes Drug Byetta Linked to Kidney Problems

November 21, 2009

The FDA has received 78 reports of kidney problems related to Byetta, a drug by Amylin Pharmaceuticals and Eli-Lilly prescribed to treat type 2 diabetes. With the new findings, the drug's label will be updated to warn doctors and patients about this possible side effect.

Byetta (exenatide) was approved in 2005. It's known as an incretin mimetic, which copies the action of incretin GLP-1, a hormone that is released in response to eating food which causes insulin to be secreted from the pancreas to lower blood glucose. The drug is injected twice a day, similar to insulin.

The drug recently was approved as a stand-alone treatment for controlling blood sugar, whereas previously it was prescribed for patients also on other diabetic therapies.

The reports of kidney failure were filed between April 2005 and October 2008. Sixty-two of the cases were for acute renal failure and 16 were cases of renal insufficiency. Most of the problems occurred in patients with pre-existing kidney disease or one or more risk factors for developing kidney problems. 91% of the patients were hospitalized, 18 required dialysis, 2 had kidney transplants, and 4 died. 80% stopped taking Byetta, and half of those patients had improvements to kidney function after discontinuing the drug.

Between 2005 and 2008, approximately 7 million prescriptions were written for Byetta. The FDA said, "Therefore, the 78 reported cases of altered renal funcion represent a small percentage of the total number of patients who have used the drug."

Some of the side effects of Byetta can contribute to kidney problems. For example, diarrhea, nausea and vomiting can lead to dehydration. Patients are encouraged to ask their physicians about their kidney function before taking Byetta and to monitor for signs and symptoms while taking the drug. Symptoms of kidney disease include changes in urine color, swelling in the feet and legs, fatigue, nausea or vomiting, and dull ache in the mid to lower back. If left untreated, kidney damage can worsen and lead to kidney failure.

Kidney malfunction may also occur as a consequence of diabetes itself, other chronic conditions, such as pancreatitis and hypertension. Concomitant use of certain medications (nonsteroidal anti-inflammatory drugs, diuretics, and antihypertensives) can also lead to kidney problems. Discontinuation of Byetta should only be considered if kidney dysfunction cannot be explained by these or other causes.

The FDA is advising physicians to avoid prescribing Byetta for patients with severe renal impairment, identified as creatinine clearance less than 30 mL per minute, or end-stage renal disease. It also recommends using caution when initiating or increasing doses from 5 micrograms to 10 micrograms in patients with moderate renal impairment. Physicians should monitor patients for the development of kidney dysfunction while on Byetta.

In 2007, Byetta was linked to a higher risk of acute pancreatitis, a potentially life-threatening inflammation of the pancreas. In October 2007 and August 2008, the FDA issued safety alerts about the reports that included cases of hemorrhagic pancreatitis and nectrotizing pancreatitis, which can be fatal. The symptoms of pancreatitis include nausea, vomiting, severe abdominal pain, a rise or fall in blood pressure, and increase heart or respiratory rates.

Adverse events for any medication should be reported to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

Denise Reynolds RD LDN



Archive issues: (50)

Archive list: 1 2 3 4 5 6 7 8 9 10 11 [12] 13 14 15 16 17

November 11, 2009 | Treatment for Sleep Apnea Can Improve Golf Game

Men with obstructive sleep apnea (OSA) who received nasal continuous positive airway pressure (NCPAP or NPAP) treatments not only improved their health, but also lowered their golf handicap by as much as three strokes, according to research presented at CHEST 2009, the 75th annual assembly of the American College of Chest Physicians (ACCP).  Obstructive sleep apnea is a condition in which a person as episodes of stopped ...

November 10, 2009 | More Insurance Companies Are Paying For Alternative Medicine

Alternative medicine which was once thought to be controversial and experimental is now gaining newfound respect within the medical community. In fact so much respect that more insurance companies are beginning to pay for alternative medicine.  More and more doctors trained in Western medicine are allowing alternative therapies are beginning to understand the power of alternative medicine and are attempting to blend Eastern and ...

November 9, 2009 | Two Antibiotics Linked to Birth Defects

Most antibiotics used during pregnancy are safe, but researchers have found a link between two commonly prescribed drugs and birth defects.  The study, part of the National Birth Defects Prevention Study and published in the November issue of Archives of Pediatrics and Adolescent Medicine, is the first analysis of antibiotic use in pregnancy. Researchers ...

Archive list: 1 2 3 4 5 6 7 8 9 10 11 [12] 13 14 15 16 17

Related articles:

Chronic bacterial prostatitis - treatment

  Treatment requires prolonged courses (4-8 weeks) of antibiotics that penetrate the prostate well (?-lactams and nitrofurantoin are ineffective). These include quinolones (ciprofloxacin, levofloxacin), sulfas (Bactrim, Septra) and macrolides (erythromycin, clarithromycin). Persistent infections may be helped in 80% of patients by the use of alpha blockers (tamsulosin (Flomax), alfuzosin), ...

Section: Prostatitis

Diagnosis

  Diagnosis has been greatly simplified in recent years with the development of two new methodologies. The Pelvic Pain Urgency/Frequency (PUF) Patient Survey, created by C. Lowell Parsons, is a short questionnaire that will help doctors identify if pelvic pain could be coming from the bladder. ...

Section: Interstitial cystitis

Alprostadil

  Alprostadil can be injected into the penis or inserted using a special applicator - usually just before sexual intercourse. Alprostadil has also become available in some countries as a topical cream (under the brand name Befar), and preliminary studies have shown a clinical efficacy of up to 83%. It has an onset of action of 10-15 minutes and its effects can last over 4 hours.    

Section: Erectile Dysfunction

News

December 20, 2009

Wii, Xbox 360 and Other Video Games Offer Some Benefits

Wii, Xbox 360, PlayStation, and other video games are hot on holiday gift lists, but some parents wonder whether these games offer any benefits or are detrimental to kids. The results of a new study may put some minds at ease, while others may not.  According to the findings reported in the latest issue of Current Directions in Psychological ...

December 18, 2009

Should You Be Shoveling Snow?

Yes, the weather outside is frightful, and soon you will have to think about shoveling snow. But should you be the one doing the work? Who should and should not shovel snow, and how can you do it safely?  Every winter, approximately ...

December 17, 2009

Athletes who take NSAID's to prevent pain may be doing more harm than good

According to Stuart Warden, a researcher who studies musculoskeletal health and sports medicine, athletes who ritualistically take NSAID's to prevent post event and workout soreness and inflammation may be depriving the body of ...

Blogroll